Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2C-B-BZP

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
2C-B-BZP
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
Identifiers
  • 1-[(4-Bromo-2,5-dimethoxyphenyl)methyl]piperazine
CAS Number
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC13H19BrN2O2
Molar mass315.211 g·mol−1
3D model (JSmol)
  • C1(=CC(=C(C=C1CN2CCNCC2)OC)Br)OC
  • InChI=1S/C13H19BrN2O2/c1-17-12-8-11(14)13(18-2)7-10(12)9-16-5-3-15-4-6-16/h7-8,15H,3-6,9H2,1-2H3 checkY
  • Key:OHXVYXBOJDDYJS-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

4-Bromo-2,5-dimethoxy-1-benzylpiperazine (2C-B-BZP) is apsychoactive drug andresearch chemical of thepiperazinechemical class which has been sold as a "designer drug".[1][2] It producesstimulant effects similar to those ofbenzylpiperazine (BZP).

Chemistry

[edit]

2C-B-BZP contains a benzylpiperazine base as well as the ring-substitution pattern of thepsychedelicphenethylamine2C-B. 2C-B-BZP is not a phenethylamine itself and does not produce psychedelic effects, as the binding groups are in the wrong position to activate the5-HT2A receptor, while the phenylpiperazine homologue2C-B-PP substitutes for DOM in DOM-trained rats with around one-tenth the potency of DOM, but does not substitute for TFMPP.[3]: 867–868 

Effects

[edit]

2C-B-BZP produces stimulant effects which last 3–6 hours. It is also said by several sources to increase the effects of other compounds when combined[citation needed]. Side effects include headaches and nausea, similar to those of other recreationally-used piperazine derivatives.

Legality

[edit]

2C-B-BZP is unscheduled and uncontrolled in theUnited States, but possession and sale of 2C-B-BZP could possibly be prosecuted under theFederal Analog Act because of its structural similarities to benzylpiperazine. 2C-B-BZP is illegal to possess, use or sell inJapan where it used to be sold in localsmartshops.

See also

[edit]

References

[edit]
  1. ^Westphal F, Junge T, Girreser U, Stobbe S, Pérez SB (May 2009). "Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazine".Forensic Science International.187 (1–3):87–96.doi:10.1016/j.forsciint.2009.03.003.PMID 19345524.
  2. ^Peters FT, Martinez-Ramirez JA (October 2010). "Analytical toxicology of emerging drugs of abuse".Therapeutic Drug Monitoring.32 (5):532–539.doi:10.1097/FTD.0b013e3181f33411.PMID 20814349.S2CID 8009246.
  3. ^Trachsel D, Lehmann D, Enzensperger C (2013).Phenethylamine: Von der Struktur zur Funktion. Nachtschatten Verlag AG.ISBN 978-3-03788-700-4.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
Phenylpiperazines
Benzylpiperazines
Naphthylpiperazines
Quinolinylpiperazines
Diphenylalkylpiperazines
Pyrimidinylpiperazines
Pyridinylpiperazines
Benzo(iso)thiazolylpiperazines
Tricyclic-linked piperazines
Others/uncategorized
Retrieved from "https://en.wikipedia.org/w/index.php?title=2C-B-BZP&oldid=1293635403"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp